Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01162135
What this trial is testing

Digoxin for Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Who this might be right for
PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more
Jonsson Comprehensive Cancer Center 92
Post-approval studies (Phase 4)Looking for participantsNCT07486843
What this trial is testing

Preventing Structural Damage in Early Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis (PsA)
Chinese University of Hong Kong 108
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Large-scale testing (Phase 3)Active Not RecruitingNCT00223145
What this trial is testing

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

Who this might be right for
Prostate Cancer
Abdenour Nabid 600
Post-approval studies (Phase 4)Study completedNCT00752869
What this trial is testing

Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement

Who this might be right for
Hypogonadism
The Miriam Hospital 24
Not applicableLooking for participantsNCT05954364
What this trial is testing

Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Women's College Hospital 540
Not applicableStudy completedNCT02155998
What this trial is testing

Non-Interventional Study PREVENT

Who this might be right for
Postoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) Patients
AstraZeneca 200
Not applicableUnknownNCT05533047
What this trial is testing

Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

Who this might be right for
PSA Changes After TURP
Assiut University 2
Post-approval studies (Phase 4)Ended earlyNCT01510847
What this trial is testing

The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM)

Who this might be right for
Assess the Effects of a the 90-day Oral TS Study Regimen on PSA, IPSS, Haemoglobin and Haematocrit, and to Assess Adverse and Serious Adverse Events.
Singapore Clinical Research Institute 19
Testing effectiveness (Phase 2)Study completedNCT01046916
What this trial is testing

Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 38
Not applicableStudy completedNCT01112449
What this trial is testing

Influence of Selenium on Prostate Cancer Related Biomarkers

Who this might be right for
Effect of Selenium on Oxidative Stress in Healthy Men
Milton S. Hershey Medical Center 130
Large-scale testing (Phase 3)Looking for participantsNCT06671483
What this trial is testing

Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Who this might be right for
Psoriatic Arthritis
Takeda 1,088
Testing effectiveness (Phase 2)UnknownNCT00309439
What this trial is testing

ALA and Prostate Cancer

Who this might be right for
Atrial FibrillationDiet TherapyProstate Cancer
University of Toronto
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Large-scale testing (Phase 3)Ended earlyNCT00514917
What this trial is testing

Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostatic Neoplasms
Sanofi 413
Large-scale testing (Phase 3)Ended earlyNCT03777982
What this trial is testing

Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 12
Not applicableStudy completedNCT00242060
What this trial is testing

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy

Who this might be right for
Elevated PSAProstate Cancer
University Health Network, Toronto
Large-scale testing (Phase 3)Active Not RecruitingNCT04908202
What this trial is testing

Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Who this might be right for
Psoriatic Arthritis
Bristol-Myers Squibb 670
Next Page